Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ)

What is diabetes distress and how can we measure it? A narrative review and conceptual model

(2017) Kathryn Dennick et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom

(2017) Lei Qin et al.   Diabetes Therapy

Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study

(2017) Lei Qin et al.   Diabetes Therapy

Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom

(2017) Lei Qin et al.   Diabetes Therapy

Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study

(2017) Lei Qin et al.   Diabetes Therapy

Exenatide Once Weekly: A Review of Pharmacology and Treatment Considerations in Type 2 Diabetes

(2016) Stephen Brunton et al.   CLINICAL THERAPEUTICS

1. Promoting Health and Reducing Disparities in Populations

(2016)   DIABETES CARE

Omarigliptin for the treatment of type 2 diabetes mellitus

(2016) Philip M. S. Evans et al.   EXPERT OPINION ON PHARMACOTHERAPY

Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in Japan

(2016) Heather Gelhorn et al.   Patient Preference and Adherence

Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors

(2016) William Polonsky et al.   Patient Preference and Adherence

Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany

(2016) Karel Kostev et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Dulaglutide: A Review in Type 2 Diabetes

(2015) Celeste B. Burness et al.   BIODRUGS

Systematic Literature Review and Meta-analysis of Medication Adherence With Once-weekly Versus Once-daily Therapy

(2015) Kristy Iglay et al.   CLINICAL THERAPEUTICS

Antidiabetic Medications and Polypharmacy

(2015) Emily P. Peron et al.   CLINICS IN GERIATRIC MEDICINE

A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes

(2015) A. Brett Hauber et al.   CURRENT MEDICAL RESEARCH AND OPINION

Review of patient-reported outcome instruments measuring health-related quality of life and satisfaction in patients with type 2 diabetes treated with oral therapy

(2015) Aude Roborel de Climens et al.   CURRENT MEDICAL RESEARCH AND OPINION

Treatment satisfaction in people with type 2 diabetes mellitus treated with once-weekly dulaglutide: data from the AWARD-1 and AWARD-3 clinical trials

(2015) M. Reaney et al.   DIABETES OBESITY & METABOLISM

First novel once-weekly DPP-4 inhibitor, trelagliptin, for the treatment of type 2 diabetes mellitus

(2015) Kohei Kaku   EXPERT OPINION ON PHARMACOTHERAPY

Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK

(2015) Heather Gelhorn et al.   Patient Preference and Adherence

Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA

(2015) Hideaki Kishimoto et al.   Archives of Osteoporosis

A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus

(2015) A. Brett Hauber et al.   Diabetes Therapy

A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus

(2015) A. Brett Hauber et al.   Diabetes Therapy

Achievement of Goals in U.S. Diabetes Care, 1999–2010

(2013) Mohammed K. Ali et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of pill burden on dosing preferences, willingness to pay, and likely adherence among patients with type 2 diabetes

(2013) A. Brett Hauber et al.   Patient Preference and Adherence

Adherence to Therapies in Patients with Type 2 Diabetes

(2013) Luis-Emilio García-Pérez et al.   Diabetes Therapy

Fixed-Dose Combinations for Treatment of Type 2 Diabetes Mellitus

(2012) Lawrence Blonde et al.   ADVANCES IN THERAPY

Persistence at 1 year of oral antiosteoporotic drugs: a prospective study in a comprehensive health insurance database

(2012) Cyrille B Confavreux et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Patient adherence to medication requirements for therapy of type 2 diabetes

(2011) C. J. Bailey et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Patient perspectives on once-weekly medications for diabetes

(2010) W. H. Polonsky et al.   DIABETES OBESITY & METABOLISM

Fixed-dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: an opportunity to improve adherence and patient care

(2010) G. Schernthaner   DIABETIC MEDICINE

Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily

(2009) J. H. Best et al.   DIABETIC MEDICINE

Improvement of glycemic control and quality-of-life by insulin lispro therapy: Assessing benefits by ITR-QOL questionnaires

(2008) Hitoshi Ishii et al.   DIABETES RESEARCH AND CLINICAL PRACTICE